Novartis AG
NVS • Drug Manufacturers - General
$159.99
▼ -3.10 (-1.90%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$306.54B
Growth
4.6%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 25.6%Positive revenue growth · 9.6%Positive free cash flow · 9.12Consistent free cash flow · 5/5Reasonable earnings multiple · 19.02
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 28, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$159.99
Change-1.90%
Shares Out1.92B
Market Cap$306.54B
Enterprise Value$344.63B
52W Range112.34 - 170.46
Beta0.49
P/E22.65
P/S5.47
P/B7.96
P/FCF17.91
EV/Sales6.15
Price$159.99
Change-1.90%
Shares Out1.92B
Market Cap$306.54B
Enterprise Value$344.63B
52W Range112.34 - 170.46
Beta0.49
P/E22.65
P/S5.47
P/B7.96
P/FCF17.91
EV/Sales6.15
EV/EBITDA15.39
EV/FCF20.13
Earnings Yield4.42%
FCF Yield5.58%
Dividend Yield2.84%
Gross Margin75.02%
Oper. Margin31.15%
Profit Margin25.64%
Debt/Eq0.80
Current Ratio1.12
Quick Ratio0.89
Revenue 5Y4.59%
FCF 5Y7.97%
Target$170.00
Target Upside6.26%
Target Median$170.00
Target Range170.00 - 170.00
Volume2.01M
Avg Volume1.64M
EPS Surprise-0.12
Investment DNA
How strong this company looks for long-term investors
82
out of 100
Business Quality
Margins, moat, returns
77/100
Financial Strength
Debt, cash, stability
69/100
Growth Potential
Revenue and expansion
94/100
Price Attractiveness
Cheap or expensive today
68/100
Why this score▼
Stable or improving margins · 25.6%Positive revenue growth · 9.6%Positive free cash flow · 9.12Consistent free cash flow · 5/5Reasonable earnings multiple · 19.02Manageable debt level · 0.8
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 25 analyst votes · 2026-09-05
58/100
Neutral
Bullish
6
Hold
17
Bearish
2
Price Target
2026-06-12
Low
$170.00
Mean
$170.00
Median
$170.00
High
$170.00
🧾
No insider activity
No recent insider transactions available.